发明名称 NOVEL PHARMACEUTICAL COMPOUNDS
摘要 The present invention relates to derivatives of tadalafil, substituted with fluorine on the methylene carbon atom situated between the oxygens of the benzodioxol ring, and optionally further substituted with deuterium atoms in place of normally abundant hydrogen, and 13C in place of normally abundant 12C. These compounds are selective PDE5 inhibitors and possess advantageous biopharmaceutical and pharmacokinetic properties. The invention further provides compositions comprising these compounds and methods of treating diseases and conditions that are responsive to PDE5 inhibition, alone and in combination with additional agents.
申请公布号 CA2616366(A1) 申请公布日期 2007.02.08
申请号 CA20062616366 申请日期 2006.07.28
申请人 CONCERT PHARMACEUTICALS INC. 发明人 TUNG, ROGER
分类号 A01N43/52;A61K31/415 主分类号 A01N43/52
代理机构 代理人
主权项
地址